Immunization, HepB3 in Europe & Central Asia (excluding high income)
Europe & Central Asia (excluding high income): Immunization, HepB3 was 92.4% in 2024. ◆ Volatile
Immunization, HepB3 in Europe & Central Asia (excluding high income), 1992–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
The most recent figure for immunization, hepb3 in Europe & Central Asia (excluding high income) is 92.4%, measured in 2024.
The figure is down 2.1% on the previous year and up 7.8% over ten years.
Over the whole period, immunization, hepb3 in Europe & Central Asia (excluding high income) peaked at 94.4% in 2019 and was at its lowest, 0.0%, in 1992.
Europe & Central Asia (excluding high income) ranks 5th of 47 groups on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in Europe & Central Asia (excluding high income), year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 1.6% | — |
| 1995 | 1.7% | +8.0% |
| 1996 | 2.9% | +65.5% |
| 1997 | 2.9% | +2.3% |
| 1998 | 6.2% | +111.3% |
| 1999 | 9.2% | +47.5% |
| 2000 | 42.2% | +360.1% |
| 2001 | 46.3% | +9.7% |
| 2002 | 67.0% | +44.8% |
| 2003 | 74.4% | +11.0% |
| 2004 | 85.3% | +14.7% |
| 2005 | 88.6% | +3.9% |
| 2006 | 88.5% | -0.1% |
| 2007 | 93.4% | +5.5% |
| 2008 | 90.6% | -3.0% |
| 2009 | 90.1% | -0.5% |
| 2010 | 89.2% | -1.0% |
| 2011 | 86.0% | -3.6% |
| 2012 | 89.2% | +3.6% |
| 2013 | 89.5% | +0.4% |
| 2014 | 85.7% | -4.2% |
| 2015 | 87.1% | +1.7% |
| 2016 | 87.1% | -0.1% |
| 2017 | 91.0% | +4.5% |
| 2018 | 93.2% | +2.5% |
| 2019 | 94.4% | +1.3% |
| 2020 | 92.0% | -2.5% |
| 2021 | 92.1% | +0.1% |
| 2022 | 93.1% | +1.0% |
| 2023 | 94.4% | +1.4% |
| 2024 | 92.4% | -2.1% |
Biggest year-on-year movements
Years where Immunization, HepB3 in Europe & Central Asia (excluding high income) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2000 | +360.1% | 9.2% | 42.2% |
| 1998 | +111.3% | 2.9% | 6.2% |
| 1996 | +65.5% | 1.7% | 2.9% |
| 1999 | +47.5% | 6.2% | 9.2% |
| 2002 | +44.8% | 46.3% | 67.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 3.1% | 0.0% | 9.2% | 8 |
| 2000s | 76.7% | 42.2% | 93.4% | 10 |
| 2010s | 89.2% | 85.7% | 94.4% | 10 |
| 2020s | 92.8% | 92.0% | 94.4% | 5 |
More health data for Europe & Central Asia (excluding high income)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 2.65 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0335 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0381 units per person (2025)
- Population ages 45-49, female, annual growth rate 2.23 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0363 units per person (2025)
- Population ages 40-44, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 10-14, male, per unit of GDP 0 units per US$ of GDP (2025)
All data for Europe & Central Asia (excluding high income) →
Frequently asked questions
- What is immunization, hepb3 in Europe & Central Asia (excluding high income)?
- Immunization, hepb3 in Europe & Central Asia (excluding high income) was 92.4% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Europe & Central Asia (excluding high income)?
- The highest recorded value was 94.4% in 2019.
- What is the lowest immunization, hepb3 recorded in Europe & Central Asia (excluding high income)?
- The lowest recorded value was 0.0% in 1992.
- How does Europe & Central Asia (excluding high income) rank for immunization, hepb3?
- Europe & Central Asia (excluding high income) ranks 5th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in Europe & Central Asia (excluding high income)?
- Over the last ten years it is up 7.8%. The long-run trend across the full record is volatile.
- Where does this Europe & Central Asia (excluding high income) data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.